Unichem Laboratories Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Unichem Laboratories Ltd. is a leading pharmaceutical company that specializes in the manufacturing and marketing of generic pharmaceuticals. With a strong presence in domestic and international markets, Unichem has established itself as a trusted name in the healthcare sector. The company was founded in 1944 and has since grown to become one of the key players in the pharmaceutical industry.

Share Price Analysis - Unichem Laboratories Ltd.

Unichem Laboratories Ltd.'s share price is an important parameter for investors looking to assess the company's performance in the stock market. Our pre-built screening tools provide an in-depth analysis of the company's share price history, enabling long-term investors to make informed decisions. The share price is influenced by various factors, including market trends, company performance, and industry outlook.

Balance Sheet Analysis - Unichem Laboratories Ltd.

Unichem Laboratories Ltd.'s balance sheet is a key financial statement that provides insights into the company's financial health. Our premium features, such as our fair value calculation tools, including DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, assist investors in evaluating the company's balance sheet. This allows investors to assess the company's financial stability and make informed investment decisions.

Annual Report - Unichem Laboratories Ltd.

The annual report of Unichem Laboratories Ltd. is a comprehensive document that provides a detailed overview of the company's performance and financial statements for the fiscal year. Investors can download the annual reports from our website to gain a deeper understanding of the company's strategies, operations, and future prospects.

Dividend Analysis - Unichem Laboratories Ltd.

Dividends are an important aspect for long-term investors. Unichem Laboratories Ltd. provides regular dividend payouts to its shareholders. By analyzing the company's dividend history, investors can assess the company's dividend policy, sustainability, and potential growth. Our pre-built screening tools help investors track dividend payouts and make informed investment decisions.

Quarterly Result Analysis - Unichem Laboratories Ltd.

Unichem Laboratories Ltd.'s quarterly results provide a snapshot of the company's financial performance during a specific period. Investors can download the quarterly results from our website to analyze key financial metrics and assess the company's growth trajectory. Our premium features, such as fair value calculation tools, provide an in-depth analysis of the quarterly results, allowing investors to evaluate the company's financial performance.

Stock Price Analysis - Unichem Laboratories Ltd.

Unichem Laboratories Ltd.'s stock price is determined by various factors, including market dynamics, investor sentiment, and company-specific factors. Our pre-built screening tools provide an analysis of the company's stock price history, allowing investors to identify trends and patterns. This analysis helps long-term investors gain insights into the company's stock price and make informed investment decisions.

Price Chart Analysis - Unichem Laboratories Ltd.

The price chart of Unichem Laboratories Ltd. provides an overview of the company's stock price movement over a specific period. Our pre-built screening tools offer interactive price charts that help investors track the company's stock price performance, identify support and resistance levels, and analyze trends. This analysis assists long-term investors in understanding the stock's historical performance and making informed investment decisions.

News and Updates - Unichem Laboratories Ltd.

Staying updated with the latest news and updates about Unichem Laboratories Ltd. is crucial for investors. Our website provides curated news articles, press releases, and market updates related to the company. These resources help investors stay informed about key developments, industry trends, and regulatory changes that may impact the company's performance.

Conference Call Transcripts - Unichem Laboratories Ltd.

Conference call transcripts provide insights into the discussions and decisions made during the company's quarterly or annual conference calls. Investors can download the conference call transcripts from our website to gain a deeper understanding of management's perspective on the company's performance, growth strategy, and future outlook. These transcripts serve as valuable resources for long-term investors looking for a comprehensive analysis.

Investor Presentations - Unichem Laboratories Ltd.

Investor presentations offered by Unichem Laboratories Ltd. provide a detailed overview of the company's business model, growth strategy, financial performance, and future outlook. Investors can download these presentations from our website to gain insights directly from the company. These presentations help investors understand the company's value proposition, innovative initiatives, and competitive advantage in the pharmaceutical industry.

Promoters and Shareholders - Unichem Laboratories Ltd.

Unichem Laboratories Ltd.'s promoters and shareholders play a crucial role in shaping the company's operations and growth. Our website provides information about the company's promoters and major shareholders, helping investors gain insights into the management's expertise, experience, and long-term vision. This information is valuable for investors looking to assess the credibility and stability of the company's ownership structure.

In conclusion, Unichem Laboratories Ltd. offers a comprehensive stock analysis page that caters to the needs of long-term stock investors. With a focus on providing relevant and accurate information, our website equips investors with the necessary tools to analyze the company's performance and make informed investment decisions. Our pre-built screening tools and premium features, such as fair value calculation tools, provide investors with valuable insights into various aspects of Unichem Laboratories Ltd.'s stock. Downloadable resources, including annual reports, conference call transcripts, and investor presentations, enable investors to delve deeper into the company's strategies and future prospects. Stay updated with the latest news and updates to stay informed about key developments in the pharmaceutical industry. Happy investing!   

Unichem Laboratories Equity and Liabilities Analysis

Examining Unichem Laboratories' balance sheet data showcases the stability and changes within the company's equity and liabilities over a span of five years. As of March 2024, the share capital has remained constant at Rs 14.08 Cr, reflecting stability in the company's equity structure. A close inspection reveals a decline in total reserves, from Rs 2,633.10 Cr in March 2020 to Rs 2,280.54 Cr by March 2024, raising questions about retained earnings and appropriations.

Unichem Laboratories Borrowings and Current Liabilities Insights

A noteworthy development in Unichem Laboratories' financials is the introduction of borrowings in March 2022, initially recorded at Rs 89.01 Cr and being progressively reduced to Rs 38.22 Cr by March 2024. This suggests a responsible approach towards debt management. The increase in current liabilities from Rs 348.27 Cr in March 2020 to Rs 487.94 Cr in March 2024, potentially indicates expanded operations or increased short-term obligations.

Unichem Laboratories Asset Allocation Over the Years

On the assets front, Unichem Laboratories has seen a substantial rise in its net block, from Rs 824.94 Cr in March 2020 to Rs 1,235.94 Cr in March 2023, before a slight drop to Rs 1,164.94 Cr in March 2024, hinting at significant capital expenditure and subsequent depreciation. Current assets saw a dip in March 2021 but have risen since, reaching Rs 1,406.13 Cr by March 2024, which could reflect an increase in inventory or receivables.

This data represents an analysis for the Standalone Balance Sheet of the company.

In assessing Unichem Laboratories' financial health, investors might also consider broader market trends, such as NSE/BSE indices, which can offer insights into how sectoral shifts might impact the company's performance. 

Unichem Laboratories Balance Sheet Analysis

Unichem Laboratories Share Capital

Unichem Laboratories has maintained its share capital consistently at Rs 14.08 Cr from March 2020 through to March 2024. This stability signifies a constant equity base over the years.

Unichem Laboratories Reserves

The company's total reserves have seen fluctuations, starting at Rs 2,633.10 Cr in March 2020, peaking in March 2021 at Rs 2,683.25 Cr, and experiencing a gradual decline to Rs 2,280.54 Cr by March 2024. The dwindling reserves indicate a decrease in retained earnings over the recent years.

Unichem Laboratories Borrowings

Initially, Unichem Laboratories reported zero borrowings up to March 2021 but then recorded an increase in March 2022 to Rs 89.01 Cr, which has been decreasing over subsequent years to Rs 38.22 Cr by March 2024. This shows a cautious approach towards leveraging.

Unichem Laboratories Assets Overview

The net block and capital work in progress (WIP) signify the company's investment in tangible assets and future projects. With the net block value rising from Rs 824.94 Cr in March 2020 to Rs 1,164.94 Cr in March 2024, it reflects ongoing and completed capital expenditures. However, capital WIP has decreased from its peak in March 2021 at Rs 567.73 Cr to Rs 122.36 Cr by March 2024, indicating a slowdown in new projects.

Unichem Laboratories Current Assets and Liabilities

Current assets have seen a varied trend, with an initial decrease in March 2021, followed by fluctuations, ultimately resulting in an increase to Rs 1,406.13 Cr by March 2024. Current liabilities have gradually increased throughout the period, pointing to a rise in short-term obligations.

This data presents a standalone balance sheet analysis for Unichem Laboratories, crucial for investors examining the financial health and operational efficiency of the company.

In the landscape of stock screening and investment, understanding such detailed balance sheet dynamics helps investors in making informed decisions not just in pharmaceutical sectors but across various sectors listed on NSE BSE indices and potential IPOs.